Table of Contents 1 Epoprostenol Sodium Drugs Market Overview 1.1 Product Overview and Scope of Epoprostenol Sodium Drugs 1.2 Epoprostenol Sodium Drugs Segment by Type 1.2.1 Global Epoprostenol Sodium Drugs Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 0.5 mg 1.2.3 1.5 mg 1.3 Epoprostenol Sodium Drugs Segment by Application 1.3.1 Epoprostenol Sodium Drugs Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital 1.3.3 Clinic 1.4 Global Epoprostenol Sodium Drugs Market Size Estimates and Forecasts 1.4.1 Global Epoprostenol Sodium Drugs Revenue 2015-2026 1.4.2 Global Epoprostenol Sodium Drugs Sales 2015-2026 1.4.3 Epoprostenol Sodium Drugs Market Size by Region: 2020 Versus 2026 2 Global Epoprostenol Sodium Drugs Market Competition by Manufacturers 2.1 Global Epoprostenol Sodium Drugs Sales Market Share by Manufacturers (2015-2020) 2.2 Global Epoprostenol Sodium Drugs Revenue Share by Manufacturers (2015-2020) 2.3 Global Epoprostenol Sodium Drugs Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Epoprostenol Sodium Drugs Manufacturing Sites, Area Served, Product Type 2.5 Epoprostenol Sodium Drugs Market Competitive Situation and Trends 2.5.1 Epoprostenol Sodium Drugs Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Epoprostenol Sodium Drugs Players (Opinion Leaders) 3 Epoprostenol Sodium Drugs Retrospective Market Scenario by Region 3.1 Global Epoprostenol Sodium Drugs Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Epoprostenol Sodium Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Epoprostenol Sodium Drugs Market Facts & Figures by Country 3.3.1 North America Epoprostenol Sodium Drugs Sales by Country 3.3.2 North America Epoprostenol Sodium Drugs Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Epoprostenol Sodium Drugs Market Facts & Figures by Country 3.4.1 Europe Epoprostenol Sodium Drugs Sales by Country 3.4.2 Europe Epoprostenol Sodium Drugs Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Epoprostenol Sodium Drugs Market Facts & Figures by Region 3.5.1 Asia Pacific Epoprostenol Sodium Drugs Sales by Region 3.5.2 Asia Pacific Epoprostenol Sodium Drugs Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Epoprostenol Sodium Drugs Market Facts & Figures by Country 3.6.1 Latin America Epoprostenol Sodium Drugs Sales by Country 3.6.2 Latin America Epoprostenol Sodium Drugs Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Epoprostenol Sodium Drugs Market Facts & Figures by Country 3.7.1 Middle East and Africa Epoprostenol Sodium Drugs Sales by Country 3.7.2 Middle East and Africa Epoprostenol Sodium Drugs Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Epoprostenol Sodium Drugs Historic Market Analysis by Type 4.1 Global Epoprostenol Sodium Drugs Sales Market Share by Type (2015-2020) 4.2 Global Epoprostenol Sodium Drugs Revenue Market Share by Type (2015-2020) 4.3 Global Epoprostenol Sodium Drugs Price Market Share by Type (2015-2020) 4.4 Global Epoprostenol Sodium Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Epoprostenol Sodium Drugs Historic Market Analysis by Application 5.1 Global Epoprostenol Sodium Drugs Sales Market Share by Application (2015-2020) 5.2 Global Epoprostenol Sodium Drugs Revenue Market Share by Application (2015-2020) 5.3 Global Epoprostenol Sodium Drugs Price by Application (2015-2020) 6 Company Profiles and Key Figures in Epoprostenol Sodium Drugs Business 6.1 GSK 6.1.1 Corporation Information 6.1.2 GSK Description, Business Overview and Total Revenue 6.1.3 GSK Epoprostenol Sodium Drugs Sales, Revenue and Gross Margin (2015-2020) 6.1.4 GSK Products Offered 6.1.5 GSK Recent Development 6.2 Teva 6.2.1 Teva Epoprostenol Sodium Drugs Production Sites and Area Served 6.2.2 Teva Description, Business Overview and Total Revenue 6.2.3 Teva Epoprostenol Sodium Drugs Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Teva Products Offered 6.2.5 Teva Recent Development 7 Epoprostenol Sodium Drugs Manufacturing Cost Analysis 7.1 Epoprostenol Sodium Drugs Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Epoprostenol Sodium Drugs 7.4 Epoprostenol Sodium Drugs Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Epoprostenol Sodium Drugs Distributors List 8.3 Epoprostenol Sodium Drugs Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Epoprostenol Sodium Drugs Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Epoprostenol Sodium Drugs by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Epoprostenol Sodium Drugs by Type (2021-2026) 10.2 Epoprostenol Sodium Drugs Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Epoprostenol Sodium Drugs by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Epoprostenol Sodium Drugs by Application (2021-2026) 10.3 Epoprostenol Sodium Drugs Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Epoprostenol Sodium Drugs by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Epoprostenol Sodium Drugs by Region (2021-2026) 10.4 North America Epoprostenol Sodium Drugs Estimates and Projections (2021-2026) 10.5 Europe Epoprostenol Sodium Drugs Estimates and Projections (2021-2026) 10.6 Asia Pacific Epoprostenol Sodium Drugs Estimates and Projections (2021-2026) 10.7 Latin America Epoprostenol Sodium Drugs Estimates and Projections (2021-2026) 10.8 Middle East and Africa Epoprostenol Sodium Drugs Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Epoprostenol Sodium Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Epoprostenol Sodium Drugs Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Epoprostenol Sodium Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Epoprostenol Sodium Drugs Manufacturers Covered in This Study Table 5. Global Epoprostenol Sodium Drugs Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Epoprostenol Sodium Drugs Sales Share by Manufacturers (2015-2020) Table 7. Global Epoprostenol Sodium Drugs Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Epoprostenol Sodium Drugs Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Epoprostenol Sodium Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Epoprostenol Sodium Drugs Sales Sites and Area Served Table 11. Manufacturers Epoprostenol Sodium Drugs Product Types Table 12. Global Epoprostenol Sodium Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Epoprostenol Sodium Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epoprostenol Sodium Drugs as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Epoprostenol Sodium Drugs Players Table 16. Global Epoprostenol Sodium Drugs Sales (K Units) by Region (2015-2020) Table 17. Global Epoprostenol Sodium Drugs Sales Market Share by Region (2015-2020) Table 18. Global Epoprostenol Sodium Drugs Revenue (Million US$) by Region (2015-2020) Table 19. Global Epoprostenol Sodium Drugs Revenue Market Share by Region (2015-2020) Table 20. North America Epoprostenol Sodium Drugs Sales by Country (2015-2020) (K Units) Table 21. North America Epoprostenol Sodium Drugs Sales Market Share by Country (2015-2020) Table 22. North America Epoprostenol Sodium Drugs Revenue by Country (2015-2020) (US$ Million) Table 23. North America Epoprostenol Sodium Drugs Revenue Market Share by Country (2015-2020) Table 24. Europe Epoprostenol Sodium Drugs Sales by Country (2015-2020) (K Units) Table 25. Europe Epoprostenol Sodium Drugs Sales Market Share by Country (2015-2020) Table 26. Europe Epoprostenol Sodium Drugs Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Epoprostenol Sodium Drugs Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Epoprostenol Sodium Drugs Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Epoprostenol Sodium Drugs Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Epoprostenol Sodium Drugs Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Epoprostenol Sodium Drugs Revenue Market Share by Region (2015-2020) Table 32. Latin America Epoprostenol Sodium Drugs Sales by Country (2015-2020) (K Units) Table 33. Latin America Epoprostenol Sodium Drugs Sales Market Share by Country (2015-2020) Table 34. Latin America Epoprostenol Sodium Drugs Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Epoprostenol Sodium Drugs Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Epoprostenol Sodium Drugs Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Epoprostenol Sodium Drugs Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Epoprostenol Sodium Drugs Revenue Market Share by Country (2015-2020) Table 40. Global Epoprostenol Sodium Drugs Sales (K Units) by Type (2015-2020) Table 41. Global Epoprostenol Sodium Drugs Sales Share by Type (2015-2020) Table 42. Global Epoprostenol Sodium Drugs Revenue (Million US$) by Type (2015-2020) Table 43. Global Epoprostenol Sodium Drugs Revenue Share by Type (2015-2020) Table 44. Global Epoprostenol Sodium Drugs Price (USD/Unit) by Type (2015-2020) Table 45. Global Epoprostenol Sodium Drugs Sales (K Units) by Application (2015-2020) Table 46. Global Epoprostenol Sodium Drugs Sales Market Share by Application (2015-2020) Table 47. Global Epoprostenol Sodium Drugs Sales Growth Rate by Application (2015-2020) Table 48. GSK Epoprostenol Sodium Drugs Corporation Information Table 49. GSK Description and Business Overview Table 50. GSK Epoprostenol Sodium Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. GSK Main Product Table 52. GSK Recent Development Table 53. Teva Epoprostenol Sodium Drugs Corporation Information Table 54. Teva Corporation Information Table 55. Teva Epoprostenol Sodium Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. Teva Main Product Table 57. Teva Recent Development Table 58. Sales Base and Market Concentration Rate of Raw Material Table 59. Key Suppliers of Raw Materials Table 60. Epoprostenol Sodium Drugs Distributors List Table 61. Epoprostenol Sodium Drugs Customers List Table 62. Market Key Trends Table 63. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 64. Key Challenges Table 65. Global Epoprostenol Sodium Drugs Sales (K Units) Forecast by Type (2021-2026) Table 66. Global Epoprostenol Sodium Drugs Sales Market Share Forecast by Type (2021-2026) Table 67. Global Epoprostenol Sodium Drugs Revenue (Million US$) Forecast by Type (2021-2026) Table 68. Global Epoprostenol Sodium Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 69. Global Epoprostenol Sodium Drugs Sales (K Units) Forecast by Application (2021-2026) Table 70. Global Epoprostenol Sodium Drugs Revenue (Million US$) Forecast by Application (2021-2026) Table 71. Global Epoprostenol Sodium Drugs Sales (K Units) Forecast by Region (2021-2026) Table 72. Global Epoprostenol Sodium Drugs Sales Market Share Forecast by Region (2021-2026) Table 73. Global Epoprostenol Sodium Drugs Revenue Forecast by Region (2021-2026) (US$ Million) Table 74. Global Epoprostenol Sodium Drugs Revenue Market Share Forecast by Region (2021-2026) Table 75. Research Programs/Design for This Report Table 76. Key Data Information from Secondary Sources Table 77. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Epoprostenol Sodium Drugs Figure 2. Global Epoprostenol Sodium Drugs Sales Market Share by Type: 2020 VS 2026 Figure 3. 0.5 mg Product Picture Figure 4. 1.5 mg Product Picture Figure 5. Global Epoprostenol Sodium Drugs Consumption Market Share by Application: 2020 VS 2026 Figure 6. Hospital Figure 7. Clinic Figure 8. Global Epoprostenol Sodium Drugs Market Size 2015-2026 (US$ Million) Figure 9. Global Epoprostenol Sodium Drugs Sales Capacity (K Units) (2015-2026) Figure 10. Global Epoprostenol Sodium Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Epoprostenol Sodium Drugs Sales Share by Manufacturers in 2020 Figure 12. Global Epoprostenol Sodium Drugs Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Epoprostenol Sodium Drugs Revenue in 2019 Figure 14. Epoprostenol Sodium Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Epoprostenol Sodium Drugs Sales Market Share by Region (2015-2020) Figure 16. Global Epoprostenol Sodium Drugs Sales Market Share by Region in 2019 Figure 17. Global Epoprostenol Sodium Drugs Revenue Market Share by Region (2015-2020) Figure 18. Global Epoprostenol Sodium Drugs Revenue Market Share by Region in 2019 Figure 19. North America Epoprostenol Sodium Drugs Sales Market Share by Country in 2019 Figure 20. North America Epoprostenol Sodium Drugs Revenue Market Share by Country in 2019 Figure 21. U.S. Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 22. U.S. Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 24. Canada Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Epoprostenol Sodium Drugs Sales Market Share by Country in 2019 Figure 26. Europe Epoprostenol Sodium Drugs Revenue Market Share by Country in 2019 Figure 27. Germany Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 28. Germany Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 30. France Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 32. U.K. Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 34. Italy Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 36. Russia Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Epoprostenol Sodium Drugs Sales Market Share by Region in 2019 Figure 38. Asia Pacific Epoprostenol Sodium Drugs Revenue Market Share by Region in 2019 Figure 39. China Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 40. China Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 42. Japan Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 44. South Korea Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 46. India Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 48. Australia Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. Taiwan Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. Indonesia Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. Thailand Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Malaysia Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 58. Philippines Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 60. Vietnam Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Epoprostenol Sodium Drugs Sales Market Share by Country in 2019 Figure 62. Latin America Epoprostenol Sodium Drugs Revenue Market Share by Country in 2019 Figure 63. Mexico Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. Mexico Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. Brazil Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. Argentina Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Epoprostenol Sodium Drugs Revenue Market Share by Country in 2019 Figure 71. Turkey Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Turkey Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Saudi Arabia Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Epoprostenol Sodium Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. U.A.E Epoprostenol Sodium Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Epoprostenol Sodium Drugs by Type (2015-2020) Figure 78. Sales Market Share of Epoprostenol Sodium Drugs by Type in 2019 Figure 79. Revenue Share of Epoprostenol Sodium Drugs by Type (2015-2020) Figure 80. Revenue Market Share of Epoprostenol Sodium Drugs by Type in 2019 Figure 81. Global Epoprostenol Sodium Drugs Sales Growth by Type (2015-2020) (K Units) Figure 82. Global Epoprostenol Sodium Drugs Sales Market Share by Application (2015-2020) Figure 83. Global Epoprostenol Sodium Drugs Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Epoprostenol Sodium Drugs by Application (2015-2020) Figure 85. Global Revenue Share of Epoprostenol Sodium Drugs by Application in 2020 Figure 86. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Price Trend of Key Raw Materials Figure 89. Manufacturing Cost Structure of Epoprostenol Sodium Drugs Figure 90. Manufacturing Process Analysis of Epoprostenol Sodium Drugs Figure 91. Epoprostenol Sodium Drugs Industrial Chain Analysis Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Porter's Five Forces Analysis Figure 95. North America Epoprostenol Sodium Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 96. North America Epoprostenol Sodium Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 97. Europe Epoprostenol Sodium Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 98. Europe Epoprostenol Sodium Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 99. Latin America Epoprostenol Sodium Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 100. Latin America Epoprostenol Sodium Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 101. Middle East and Africa Epoprostenol Sodium Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 102. Middle East and Africa Epoprostenol Sodium Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Asia Pacific Epoprostenol Sodium Drugs Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 104. Asia Pacific Epoprostenol Sodium Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Bottom-up and Top-down Approaches for This Report Figure 106. Data Triangulation Figure 107. Key Executives Interviewed

GSK Teva